Death related to consumption of Rauvolfia sp. powder mislabeled as Tabernanthe iboga

Glick, 1991, Effects and after effects of ibogaine on morphine self-administration in rats, Eur. J. Pharmacol., 195, 341, 10.1016/0014-2999(91)90474-5 Dzoljic, 1988, Effect of ibogaine on naloxone precipitated withdrawal syndrome in chronic morphine-dependent rats, Arch. Int. Pharmacodyn. Ther., 294, 64 Cappendijk, 1993, Inhibitory effects of ibogaine on cocaine self-administration in rats, Eur. J. Pharmacol., 241, 261, 10.1016/0014-2999(93)90212-Z Rezvani, 1995, Attenuation of alcohol intake by ibogaine in three strains of alcohol preferring rats, Pharmacol. Biochem. Behav., 52, 615, 10.1016/0091-3057(95)00152-M Brown, 2013, Ibogaine in the treatment of substance dependence, Curr. Drug Abuse Rev., 6, 3, 10.2174/15672050113109990001 Alper, 1999, Treatment of acute opioid withdrawal with ibogaine, Am. J. Addict., 8, 234, 10.1080/105504999305848 H.S. Lotsof, Rapid method for interrupting the narcotic addiction syndrome, US. Patent. No. 4449096 (1985). Delourmé-Houdé, 1946, Contribution à l’étude de l’iboga (Tabernanthe iboga H. Bn), Ann. Pharm. Fra., 4, 30 Cooper, 2012, Society of Hair Testing guidelines for drug testing in hair, Forensic Sci. Int., 218, 20, 10.1016/j.forsciint.2011.10.024 Hamet, 1944, 251 Rathi, 2013, Therapeutic characteristics of Rauvolfia serpentine, Int. J. Pharm. Sci., 2, 1038 Kumari, 2013, Benth ex Kurz.: phytochemical, pharmacological and therapeutic aspects, Int. J. Pharm. Sci. Rev., 23, 348 Vanbinst, 2002, Bile analysis of drugs in postmortem cases, Forensic Sci. Int., 128, 35, 10.1016/S0379-0738(02)00161-5 Regenthal, 1999, Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs, J. Clin. Monit. Comput., 15, 529, 10.1023/A:1009935116877 Maass, 1969, Studies on absorption, excretion, and metabolism of 3H-reserpine in man, Clin. Pharmacol. Ther., 10, 366, 10.1002/cpt1969103366 Bronstein, 2010, 2009 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 27th annual report, Clin. Toxicol., 48, 979, 10.3109/15563650.2010.543906 Mehrotra, 2015, Hairy root biotechnology of Rauwolfia serpentina: a potent approach for the production of pharmaceutically important terpenoid indole alkaloids, Biotechnol. Lett., 37, 253, 10.1007/s10529-014-1695-y Nammi, 2005, Reserpine-induced central effects: pharmacological evidence for the lack of central effects of reserpine methiodide, Can. J. Physiol. Pharmacol., 83, 509, 10.1139/y05-039 International Programme on Chemical Safety; Poisons Information Monograph: Reserpine (PIM 467), available at: http://www.inchem.org/documents/pims/pharm/reserpn.htm (consulted 05.08.15). Rudnick, 1990, Energetics of reserpine binding and occlusion by the chromaffin granule biogenic amine transporter, Biochemistry, 29, 603, 10.1021/bi00455a002 Hoffman, 2011, Adrenergic pharmacology, 132 Vakil, 1949, A clinical trial of Rauwolfia serpentina in essential hypertension, Br. Heart J., 11, 350, 10.1136/hrt.11.4.350 Stitzel, 1976, The biological fate of reserpine, Pharmacol. Rev., 28, 179 Good, 2008, Rauwolfia serpentina toxicity in a dog, J. Vet. Emerg. Crit. Care, 18, 654, 10.1111/j.1476-4431.2008.00367.x Baselt, 2014, 2211 Rolf, 2003, The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol, Eur. Heart J., 24, 1104, 10.1016/S0195-668X(03)00195-7 Pinar Bermúdez, 2000, Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome, Pacing. Clin. Electrophysiol., 23, 407, 10.1111/j.1540-8159.2000.tb06771.x Jornod, 1965, Suicidal attempt by overdosage of ajmaline, Am. Heart J., 70, 719, 10.1016/0002-8703(65)90402-3 Medina-Ravell, 1984, Nonfatal ajmaline cardiotoxicity, Am. J. Cardiol., 53, 958, 10.1016/0002-9149(84)90536-8 Wellens, 1980, Death after ajmaline administration, Am. J. Cardiol., 45, 905, 10.1016/0002-9149(80)90139-3 Köppel, 1990, Clinical course and outcome in class IC antiarrhythmic overdose, J. Toxicol. Clin. Toxicol., 28, 433, 10.3109/15563659009038586 Anderson, 2013, Case study: two fatal case reports of acute yohimbine intoxication, J. Anal. Toxicol., 37, 611, 10.1093/jat/bkt057 Le Corre, 1999, Biopharmaceutics and metabolism of yohimbine in humans, Eur. J. Pharm. Sci., 9, 79, 10.1016/S0928-0987(99)00046-9 Linden, 1985, Yohimbine: a new street drug, Ann. Emerg. Med., 14, 1002, 10.1016/S0196-0644(85)80249-3 Varkey, 1992, Overdose of yohimbine, BMJ, 304, 548, 10.1136/bmj.304.6826.548-a Karioti, 2014, Combined HPLC–DAD-MS, HPLC–MS(n) and NMR spectroscopy for quality control of plant extracts: the case of a commercial blend sold as dietary supplement, J. Pharm. Biomed. Anal., 88, 7, 10.1016/j.jpba.2013.07.040